Berkshire NHS Priorities Committee

Our policies are listed in policy number order. You can download a policy by clicking on the Policy name. All policies are in Adobe 'PDF' format, you can download it for free here.

If you cannot find a specific policy you can search for it here.

All policies displayed here are the latest revisions. If the specific policy you are concerned with appears to be out of date then it is probably awaiting review. If you would like confirmation of a policies status, you can contact us using this Email address, (please ensure that you detail the policy name, or number).

Policy name / Description	Policy number
South Central Priorities Committee: MOBBB Index of Policy Statements	0
South Central Priorities Committee: MOBBB Index of Policy Statements

BERKSHIRE PRIORITIES COMMITTEE INDEX OF POLICY DECISIONS	0
BERKSHIRE PRIORITIES COMMITTEE INDEX OF POLICY DECISIONS

South Central Ethical Framework	0
The purpose of the ethical framework is to support and underpin the decision making processes of constituent organisations and their Priorities Committees to support consistent commissioning policy through: • Providing a coherent structure for discussion, ensuring all important aspects of each issue are considered • Promoting fairness and consistency in decision making from meeting to meeting and with regard to different clinical topics, reducing the potential for inequity • Providing a means of expressing the reasons behind the decisions made. • Reducing risk of judicial review by implementation of robust decision-making processes that are based on evidence of clinical and cost effectiveness and an ethical framework • Supporting and integrating with the development of PCT Commissioning Plans

MOBBB Policy 01 - Alemtuzumab for B-cell chronic lymphocytic leukaemia	1
Alemtuzumab for B-cell chronic lymphocytic leukaemia

The use of Zanamivir, Oseltamivir & Amantadine Ref TV1 for the TREATMENT of Influenza	1
NICE has made recommendations of the use of Zanamivir, Oseltamivir and Amantadine for the treatment of influenza. Following NHS Directions to PCTs, funds will be normally available to accommodate the costs should clinicians decide it is appropriate. Clinicians remain responsible for deciding if the treatment is appropriate for individual patients. Keywords: influenza / Zanamivir / Oseltamivir /Amantadine

Clopidogrel in the treatment of non-STsegment-elevation acute coronary syndrome - 2b	2
NICE has published guidance on the use of Clopidogrel in the treatment of non-ST segment-elevation acute coronary syndrome (TAG80); Clopidogrel, in combination with low-dose aspirin, is recommended for use in the management of non-ST-segment-elevation acute coronary syndrome (ACS) in people who are at moderate to high risk of myocardial infarction (MI) or death. The South Central Priorities Committees recommend that this guidance be adopted.

MOBBB Policy 02 - Aprepitant for chemotherapy-induced nausea and vomiting	2
Aprepitant for chemotherapy-induced nausea and vomiting

MOBBB Policy 03 - Bendamustine in the treatment of relapsed or refractory	3
Bendamustine in the treatment of relapsed or refractory non-Hodgkin’s lymphoma

Manipulation of the Temporomandibular Joint with Intraarticuar Injection of Steroids under General Anaesthesia	3
Manipulation of the Temporomandibular Joint together with Intra-articuar Injection of Steroids under General Anaesthesia Keywords: TMJ/temporomandibular joint

Gender Reassignment Surgery for the Treatment of Gender Dysphoria in Adults - 4b	4
Gender Dysphoria is a psychological state whereby a person demonstrates dissatisfaction with their biological sex, and requests sex reassignment. Management can be lengthy and arduous. • There is a clear consensus that equitable access to services for initial diagnostic assessment, hormone therapy and surgery is essential for those patients fulfilling the World Professional Association for Transgender Health (WPATH) Standards of Care criteria. • There is no professional consensus on the classification of core and non-core procedures for gender reassignment. • There is limited evidence to suggest that gender reassignment surgery is effective. Much of the evidence in favour of or against gender reassignment surgery is of poor quality due to lack of standardised criteria for assessment and management, short term follow up and outcomes. • For most gender reassignment surgical (GRS) procedures, several techniques have been described with varying degrees of complications and patient satisfaction reported. In view of the heterogeneity of surgical techniques, outcomes, complications and patient choice, it is not appropriate to recommend any particular technique or procedure for all patients. • There is no published evidence on cost-effectiveness of gender reassignment surgery.

[1/23]